Erste Group Bank downgraded shares of Intuitive Surgical (NASDAQ:ISRG – Free Report) from a strong-buy rating to a hold rating in a research report released on Monday morning,Zacks.com reports.
Other equities research analysts have also recently issued research reports about the company. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Raymond James upped their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Citigroup increased their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Barclays increased their price target on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Royal Bank of Canada increased their price target on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $611.86.
Get Our Latest Report on Intuitive Surgical
Intuitive Surgical Stock Down 1.0 %
Insider Buying and Selling at Intuitive Surgical
In other news, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 408 shares of the stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares in the company, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 in the last ninety days. 0.90% of the stock is currently owned by corporate insiders.
Institutional Trading of Intuitive Surgical
Large investors have recently modified their holdings of the stock. Howard Capital Management Group LLC boosted its stake in Intuitive Surgical by 4.5% in the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after buying an additional 92 shares in the last quarter. Principal Financial Group Inc. boosted its stake in Intuitive Surgical by 1.5% in the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after buying an additional 9,194 shares in the last quarter. Quest Partners LLC acquired a new stake in Intuitive Surgical in the third quarter valued at about $173,000. Pathstone Holdings LLC boosted its stake in Intuitive Surgical by 2.6% in the third quarter. Pathstone Holdings LLC now owns 48,928 shares of the medical equipment provider’s stock valued at $24,037,000 after buying an additional 1,228 shares in the last quarter. Finally, Banque Cantonale Vaudoise boosted its stake in Intuitive Surgical by 6.1% in the third quarter. Banque Cantonale Vaudoise now owns 8,332 shares of the medical equipment provider’s stock valued at $4,094,000 after buying an additional 480 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Top Biotech Stocks: Exploring Innovation Opportunities
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3 Must-Own Stocks to Build Wealth This Decade
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.